• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Risedronate Teva
    / Abic


    Active Ingredient

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    4 X 35 mg

    partial basket chart 30577 18457

    Related information


    Dosage

    See prescribing information for full details.


    Indications

    Treatment of postmenopausal osteoporosis, to reduce the risk of vertebral fractures. Treatment of established postmenopausal osteoporosis, to reduce the risk of hip fractures. Prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis. Treatment of osteoporosis in men at high risk of fracture.


    Contra-Indications

    Known hypersensitivity to risedronate sodium or to any other ingredient of the product. Inability to stand or sit upright for at least 30 minutes. Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia. Hypocalcemia. Pregnancy and lactation. Severe renal impairment.


    Special Precautions

    Please contact distributing company for full details.


    Side Effects

    Please contact distributing company for full details.


    Drug interactions

    Please contact distributing company for full details.


    Manufacturer
    Teva Hungary
    CLOSE